Cryogenic 3D Printing of GelMA/Graphene Bioinks: Improved Mechanical Strength and Structural Properties for Tissue Engineering

• Published in: International journal of nanomedicine Vol. 19; pp. 10745 - 10765
• Main Authors: Santana, Moises das Virgens, Magulas, Maria Beatriz S, Brito, Guilherme Castro, Santos, Mariana Chaves, de Oliveira, Tainara Gomes, de Melo, Wanderson Gabriel Gomes, Argolo Neto, Napoleao Martins, Marciano, Fernanda Roberta, Viana, Bartolomeu Cruz, Lobo, Anderson Oliveira
• Format: Journal Article
• Language: English
• Published: New Zealand Dove 01.01.2024; Dove Medical Press
• Subjects: Animals; Biocompatible Materials - chemistry; Biocompatible Materials - pharmacology; Cell Survival - drug effects; Chick Embryo; Chorioallantoic Membrane - drug effects; Compressive Strength; cryoprinting; Gelatin - chemistry; gelma; graphene; Graphite - chemistry; Humans; Hydrogels - chemistry; Hydrogels - pharmacology; hydrogels and tissue engineering; Ink; Materials Testing; Methacrylates - chemistry; Original Research; Printing, Three-Dimensional; Tissue Engineering - methods; Tissue Scaffolds - chemistry; cryoprinting; GelMA; hydrogels and tissue engineering; graphene
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S486868

Tissue engineering aims to recreate natural cellular environments to facilitate tissue regeneration. Gelatin methacrylate (GelMA) is widely utilized for its biocompatibility, ability to support cell adhesion and proliferation, and adjustable mechanical characteristics. This study developed a GelMA and graphene bioink platform at concentrations of 1, 1.5, and 2 mg/mL to enhance scaffold properties for tissue engineering applications. Graphene was incorporated into GelMA matrices to improve mechanical strength and electrical conductivity of the bioinks. The compressive strength and thermal stability of the resulting GelMA/graphene scaffolds were assessed through DSC analysis and mechanical testing. Cytotoxicity assays were conducted to determine cell survival rates. Cryoprinting at -30°C was employed to preserve scaffold structure and function. The chorioallantoic membrane (CAM) assay was used to evaluate biocompatibility and angiogenic potential. The integration of graphene significantly amplified the compressive strength and thermal stability of GelMA scaffolds. Cytotoxicity assays indicated robust cell survival rates of 90%, confirming the biocompatibility of the developed materials. Cryoprinting effectively preserved scaffold integrity and functionality. The CAM assay validated the biocompatibility and angiogenic potential, demonstrating substantial vascularization upon scaffold implantation onto chick embryo CAM. Integrating graphene into GelMA hydrogels, coupled with low-temperature 3D printing, represents a potent strategy for enhancing scaffold fabrication. The resultant GelMA/graphene scaffolds exhibit superior mechanical properties, biocompatibility, and pro-vascularization capabilities, making them highly suitable for diverse tissue engineering and regenerative medicine applications.